Ana-Luisa Reis

Title: Ana-Luisa Reis: Innovator in African Swine Fever Vaccine Development

Introduction

Ana-Luisa Reis is a prominent inventor based in Woking, GB. She has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for African Swine Fever (ASF). With a total of 2 patents, her work is crucial in combating this devastating disease that affects swine populations.

Latest Patents

Ana-Luisa Reis's latest patents focus on an attenuated African Swine Fever virus vaccine. The first patent provides an attenuated ASF virus that lacks functional versions of specific genes, including the DP148R gene. This invention also includes a vaccine that utilizes this attenuated virus to prevent ASF. Additionally, it explores the intranasal administration of the attenuated ASF virus. The second patent similarly addresses an attenuated ASF virus, which lacks functional versions of multigene-family 360 genes and multigene-family 505 genes, along with the DP148R gene. This patent also emphasizes the vaccine's potential for preventing ASF through intranasal administration.

Career Highlights

Ana-Luisa Reis is affiliated with The Pirbright Institute, where she conducts her research and development work. Her innovative approach to vaccine development has positioned her as a key figure in the fight against ASF.

Collaborations

Ana-Luisa collaborates with notable colleagues, including Charles Abrams and Chris Netherton. Their combined expertise enhances the research efforts at The Pirbright Institute.

Conclusion

Ana-Luisa Reis is a dedicated inventor whose work on African Swine Fever vaccines is making a significant impact in veterinary medicine. Her innovative patents and collaborations are paving the way for advancements in disease prevention for swine populations.